105 related articles for article (PubMed ID: 12684572)
1. [The bank of biological material in the SU.VI.MAX study].
Galan P; Favier A; Preziosi P; Bertrais S; Arnault N; Hercberg S
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):147-50. PubMed ID: 12684572
[TBL] [Abstract][Full Text] [Related]
2. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study.
Hercberg S; Galan P; Preziosi P; Roussel AM; Arnaud J; Richard MJ; Malvy D; Paul-Dauphin A; Briançon S; Favier A
Int J Vitam Nutr Res; 1998; 68(1):3-20. PubMed ID: 9503043
[TBL] [Abstract][Full Text] [Related]
3. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
[TBL] [Abstract][Full Text] [Related]
4. [Antioxidant micronutrients and chronic degenerative pathology: the role of complementary nutritional doses].
Hercberg S
Bull Mem Acad R Med Belg; 1997; 152(10-11):379-85; discussion 385-7. PubMed ID: 9627441
[TBL] [Abstract][Full Text] [Related]
5. Dietary fibre intake and clinical indices in the French Supplementation en Vitamines et Minéraux AntioXydants (SU.VI.MAX) adult cohort.
Lairon D; Bertrais S; Vincent S; Arnault N; Galan P; Boutron MC; Hercberg S;
Proc Nutr Soc; 2003 Feb; 62(1):11-5. PubMed ID: 12740051
[TBL] [Abstract][Full Text] [Related]
6. "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants.
Hercberg S; Preziosi P; Galan P; Faure H; Arnaud J; Duport N; Malvy D; Roussel AM; Briançon S; Favier A
Food Chem Toxicol; 1999; 37(9-10):925-30. PubMed ID: 10541446
[TBL] [Abstract][Full Text] [Related]
7. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants.
Hercberg S; Preziosi P; Briançon S; Galan P; Triol I; Malvy D; Roussel AM; Favier A
Control Clin Trials; 1998 Aug; 19(4):336-51. PubMed ID: 9683310
[TBL] [Abstract][Full Text] [Related]
8. Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX study.
Bruckert E; Czernichow S; Bertrais S; Paillard F; Tichet J; Galan P; Castetbon K; Hercberg S
Prev Med; 2005 Jun; 40(6):803-11. PubMed ID: 15850882
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial.
Faure H; Preziosi P; Roussel AM; Bertrais S; Galan P; Hercberg S; Favier A
Eur J Clin Nutr; 2006 Jun; 60(6):706-17. PubMed ID: 16391586
[TBL] [Abstract][Full Text] [Related]
10. [The SUVIMAX (France) study: the role of antioxidants in the prevention of cancer and cardiovascular disorders].
Vázquez Martínez C; Galán P; Preziosi P; Ribas L; Serra LL; Hercberg S
Rev Esp Salud Publica; 1998; 72(3):173-83. PubMed ID: 9810825
[TBL] [Abstract][Full Text] [Related]
11. [Biological banks of the prospective cohort PRIME Study].
Luc G; Ferri res J; Evans A; Amouyel P; Arveiler D; Cambien F; Fruchart JC; Ducimetière P;
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):159-66. PubMed ID: 12684574
[TBL] [Abstract][Full Text] [Related]
12. [Antioxidant supplements and risk of hypertension in the SU.VI.MAX trial: relationship to plasma antioxidants].
Czernichow S; Bertrais S; Blacher J; Galan P; Briançon S; Favier A; Safar M; Hercberg S
Arch Mal Coeur Vaiss; 2006; 99(7-8):665-8. PubMed ID: 17061440
[TBL] [Abstract][Full Text] [Related]
13. The SU.VI.MAX trial on antioxidants.
Hercberg S; Galan P; Preziosi P; Malvy M; Briançon S; Ait HM; Rahim B; Favier A
IARC Sci Publ; 2002; 156():451-5. PubMed ID: 12484233
[No Abstract] [Full Text] [Related]
14. [Management of the bank of biological material in the hospital-based SEROCO and HEMOCO cohorts of HIV-infected patients].
Meyer L; Gharib M; Lerable J; Sarr A; Boufassa F; Deveau C; Boucherit S; Chaib A; Hubert JB; Persoz A; Delfraissy JF; Rouzioux C
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):151-8. PubMed ID: 12684573
[TBL] [Abstract][Full Text] [Related]
15. Impact of 6-year body weight change on cardiac geometry and function in ageing adults: the SUpplémentation en Vitamines et Minéraux AntioXydants -2 (SU.VI.MAX-2) cardiovascular ultrasound substudy.
Monsuez JJ; Kesse-Guyot E; Fezeu L; Blacher J; Galan P; Sebbane G; Hercberg S; Czernichow S
J Hypertens; 2010 Nov; 28(11):2309-15. PubMed ID: 20706135
[TBL] [Abstract][Full Text] [Related]
16. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
Hercberg S; Galan P; Preziosi P; Bertrais S; Mennen L; Malvy D; Roussel AM; Favier A; Briançon S
Arch Intern Med; 2004 Nov; 164(21):2335-42. PubMed ID: 15557412
[TBL] [Abstract][Full Text] [Related]
17. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
[TBL] [Abstract][Full Text] [Related]
18. [Constitution of a bank of biological material in the French Gazel cohort: logistical and practical aspects].
Zins M; Ozguler A; Bonenfant S; Henny J; Goldberg M
Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):143-6. PubMed ID: 12684571
[TBL] [Abstract][Full Text] [Related]
19. Physical activity does not influence the effect of antioxidant supplementation at nutritional doses on the incidence of impaired fasting glucose: a 7.5 year post-hoc analysis from the SU.VI.MAX study.
Fezeu L; Henegar A; Kesse-Guyot E; Julia C; Galan P; Hercberg S; Ristow M; Czernichow S
Horm Metab Res; 2010 Oct; 42(11):826-7. PubMed ID: 20665424
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant vitamins and minerals in prevention of cancers: lessons from the SU.VI.MAX study.
Hercberg S; Czernichow S; Galan P
Br J Nutr; 2006 Aug; 96 Suppl 1():S28-30. PubMed ID: 16923246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
